Can combining Suprecur (buserelin acetate) injection with gonadotropins increase the risk of ovarian hyperstimulation syndrome?

Combining Suprecur (buserelin acetate) injection with gonadotropins may increase ovarian hyperstimulation syndrome (OHSS) risk compared with gonadotropins alone, with particular caution recommended in patients with polycystic ovarian syndrome.